| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |